Results 111 to 120 of about 508,488 (299)
The Effects of Private Equity-Backing in the European Acquisitions of Unlisted Companies. [PDF]
Using a sample of acquisitions of unlisted firms completed by public companies from 17 Western European countries over the period 2003-2008, this study investigates whether private equity (PE)-backing of acquired firms has an impact on announcement ...
Joly, Vanessa
core
Molecular Oncology, EarlyView.Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece +18 more
wiley +1 more source
Human vaccines & immunotherapeutics: News October 2023
Human Vaccines & Immunotherapeutics, 2023 Ronald Ellis, Adam Weiss
doaj +1 more source
Do shareholders of acquiring firms gain from acquisitions? [PDF]
We examine a sample of 12,023 acquisitions by public firms from 1980 to 2001. Shareholders of these firms lost a total of $218 billion when acquisitions were announced.
Frederik P. Schlingemann +2 more
core
Survivin and Aurora Kinase A control cell fate decisions during mitosis
Molecular Oncology, EarlyView.Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir +2 more
wiley +1 more source
Human vaccines & immunotherapeutics: news April 2022
Human Vaccines & Immunotherapeutics, 2022 Ron Ellis, Adam Weiss
doaj +1 more source
Learning by observing: information spillovers in the execution and valuation of commercial bank M&As [PDF]
We hypothesize that banks become better able to manage acquisitions, and investors become better able to value those acquisitions, as these parties ‘learn-by-observing’ information that spills-over from previous bank M&As.
Gayle DeLong, Robert DeYoung
core
Molecular Oncology, EarlyView.CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir +12 more
wiley +1 more source
Do takeovers create value? A residual income approach on UK data [PDF]
This paper develops and empirically tests a new methodology for evaluating the financial performance of takeovers. The existing accounting and event study methodologies do not adequately address the key issue of whether takeovers are a positive net ...
Andy Cosh +3 more
core